OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Galenica AG/  CH0360674466  /

Cboe Europe BXE
11/11/2024  5:18:52 PM Chg. - Volume Bid9:10:27 AM Ask9:13:38 AM Market Capitalization Dividend Y. P/E Ratio
76.78CHF - 3,759
Turnover: 288,521.93		 76.10Bid Size: 10 76.35Ask Size: 81 3.83 bill.CHF 2.87% 13.40
GlobeNewswire 7/31 Santhera Appoints Dr. Oliver P. Kronenberg as Chief Legal Officer and Company Secretary
GlobeNewswire 7/25 Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOL...
GlobeNewswire 9/18/2023 AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
GlobeNewswire 11/17/2021 Biofrontera reports financial results for the third quarter and nine months ended September 30, 2021
GlobeNewswire 8/19/2021 Biofrontera reports financial results for the six months ended June 30, 2021
GlobeNewswire 7/6/2021 Biofrontera reports preliminary revenue for the month of June 2021
GlobeNewswire 4/12/2021 Biofrontera reports results for the 2020 financial year
GlobeNewswire 12/7/2020 Biofrontera enters into a license and supply agreement with Galenica AB for the marketing of Ameluz®...
GlobeNewswire 9/10/2020 Opthea Appoints US-Based Non-Executive Director
GlobeNewswire 5/21/2020 Atreca Announces Appointment of Kristine M. Ball to its Board of Directors
GlobeNewswire 7/11/2019 Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer...
GlobeNewswire 6/18/2019 Menlo Therapeutics Announces Addition of Ronald A. Krasnow as General Counsel and Chief Compliance O...
GlobeNewswire 8/28/2018 VIFOR PHARMA ISSUES INAUGURAL CHF 465 MILLION BOND
GlobeNewswire 6/25/2018 NodThera secures £28 million ($40 million) Series A Financing
GlobeNewswire 5/23/2018 Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Enter into Ex-U.S. Licensin...
GlobeNewswire 5/23/2018 VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE...
GlobeNewswire 5/15/2018 90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING
GlobeNewswire 5/15/2018 90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING
GlobeNewswire 5/8/2018 Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa®...
GlobeNewswire 5/8/2018 US FDA APPROVES USE OF VELTASSA® WITH OR WITHOUT FOOD
GlobeNewswire 4/16/2018 Relypsa Funds Three Innovative Research Projects on Hyperkalemia and Associated Disorders
GlobeNewswire 4/11/2018 Relypsa Presents Patiromer Clinical Trial Data on Serum Potassium in Patients with Hyperkalemia at t...
GlobeNewswire 3/29/2018 VIFOR PHARMA TO PROPOSE JACQUES THEURILLAT AS BOARD MEMBER
GlobeNewswire 3/27/2018 VIFOR PHARMA CONCLUDES LICENSING AGREEMENT WITH ZERIA TO MARKET VELTASSA® IN JAPAN
GlobeNewswire 3/15/2018 VIFOR PHARMA GROUP REPORTS STRONG 2017 RESULTS, EXCEEDING RAISED GUIDANCE